V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280007646 | 280004941 | null | 69 | Palliative (P) | 2017-02-02 | 2017-02-24 | Cetuximab 7 day (>Cycle 2) | N | N | 280025198 | CETUXIMAB |
| 280007647 | 280008615 | null | 81 | Neo-adjuvant (N) | null | 2014-02-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025200 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007648 | 280008616 | 1.7 | 70 | Palliative (P) | 2015-08-21 | 2015-08-26 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | N | 280025201 | NOT MATCHED |
| 280007649 | 280004946 | 1.71 | 106 | Palliative (P) | 2018-05-19 | 2018-05-19 | Cetuximab 7 day (>Cycle 2) | N | N | 280025204 | CETUXIMAB |
| 280007650 | 280010365 | 1.88 | 85.5 | Palliative (P) | 2016-05-22 | 2016-05-27 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280025204 | DOCETAXEL + GEMCITABINE |
| 280007651 | 280004948 | null | 16.4 | Palliative (P) | 2017-02-19 | 2017-04-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280025207 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007652 | 280004949 | 1.62 | 69 | Curative (C) | 2014-09-15 | 2014-10-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280025207 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007653 | 280004949 | 1.71 | 80.3 | Palliative (P) | 2015-10-12 | 2015-10-12 | CARBOPLATIN | N | N | 280025207 | CARBOPLATIN |
| 280007654 | 280004950 | 1.67 | null | Not known (9) | 2014-04-18 | 2014-05-21 | CETUXIMAB | N | Y | 280025212 | CETUXIMAB |
| 280007655 | 280010367 | 1.76 | null | Palliative (P) | 2018-07-31 | 2018-08-10 | DOCETAXEL + GEMCITABINE | N | N | 280025212 | DOCETAXEL + GEMCITABINE |
| 280007656 | 280010367 | 1.79 | null | Palliative (P) | null | 2017-12-25 | Docetaxel + Gemcitabine (prior RT) | Y | null | 280025212 | DOCETAXEL + GEMCITABINE |
| 280007657 | 280004953 | 1.5 | 62.1 | Palliative (P) | null | 2016-03-06 | Carboplatin AUC 6 - 10 | N | null | 280025223 | CARBOPLATIN |
| 280007658 | 280004953 | null | 50.6 | Palliative (P) | 2014-06-13 | 2014-06-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025223 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007659 | 280004954 | 1.68 | 65 | Palliative (P) | 2017-05-13 | 2017-06-18 | CETUXIMAB | N | N | 280025230 | CETUXIMAB |
| 280007660 | 280004954 | 1.65 | 72.6 | Palliative (P) | 2016-05-20 | 2016-06-30 | Carboplatin AUC 2 - 5 | 02 | N | 280025230 | CARBOPLATIN |
| 280007661 | 280004955 | 0 | 36.6 | null | 2015-03-22 | 2015-08-30 | Olaratumab | 02 | N | 280025237 | NOT MATCHED |
| 280007662 | 280004957 | 1.73 | null | Palliative (P) | null | 2016-09-23 | DOCETAXEL + GEMCITABINE | N | null | 280025238 | DOCETAXEL + GEMCITABINE |
| 280007663 | 280004958 | 1.68 | null | Palliative (P) | 2016-03-26 | 2016-03-26 | CETUXIMAB | null | null | 280025238 | CETUXIMAB |
| 280007664 | 280008624 | null | null | Palliative (P) | 2017-08-05 | 2017-08-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025243 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007665 | 280004960 | 1.5 | null | null | 2015-09-17 | 2015-11-06 | Carboplatin AUC 6 - 10 | N | N | 280025243 | CARBOPLATIN |
| 280007666 | 280010370 | 1.67 | 85.999 | Palliative (P) | 2013-06-03 | 2013-10-06 | DOCETAXEL + GEMCITABINE | N | null | 280025253 | DOCETAXEL + GEMCITABINE |
| 280007667 | 280010370 | 0 | 93.2 | Palliative (P) | 2016-08-19 | 2016-08-22 | null | null | null | 280025253 | NOT MATCHED |
| 280007668 | 280010370 | 1.6 | 78.5 | Palliative (P) | 2017-03-28 | 2017-04-04 | DOCETAXEL + GEMCITABINE | 01 | N | 280025253 | DOCETAXEL + GEMCITABINE |
| 280007669 | 280010370 | 0 | 71.4 | Palliative (P) | 2017-01-10 | 2017-02-07 | Carboplatin AUC 6 - 10 | Y | N | 280025253 | CARBOPLATIN |
| 280007670 | 280004961 | 1.69 | 8.4 | Palliative (P) | 2016-02-23 | 2016-03-23 | Docetaxel + Gemcitabine (prior RT) | N | N | 280025258 | DOCETAXEL + GEMCITABINE |
| 280007671 | 280008626 | 0 | 55.3 | Palliative (P) | 2012-09-07 | 2013-08-29 | Olaratumab | 2 | N | 280025260 | NOT MATCHED |
| 280007672 | 280004965 | 1.63 | 18.2 | Palliative (P) | 2014-02-04 | 2014-03-19 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025260 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007673 | 280004966 | 1.7 | 87.2 | Palliative (P) | 2013-02-17 | 2013-06-23 | DOCETAXEL + GEMCITABINE | null | null | 280025261 | DOCETAXEL + GEMCITABINE |
| 280007674 | 280004966 | 1.71 | null | Palliative (P) | 2016-04-22 | 2016-05-28 | Cetuximab 7 day (>Cycle 2) | null | null | 280025261 | CETUXIMAB |
| 280007675 | 280004967 | null | 73.4 | Palliative (P) | 2014-01-19 | 2014-01-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025266 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007676 | 280010372 | 1.78 | 83.1 | Palliative (P) | 2014-11-07 | 2014-11-10 | Cetuximab 7 day (>Cycle 2) | N | N | 280025269 | CETUXIMAB |
| 280007677 | 280010372 | 1.8 | 85.9 | Palliative (P) | 2016-09-08 | 2016-09-18 | Cetuximab 7 day (>Cycle 2) | 2 | N | 280025269 | CETUXIMAB |
| 280007678 | 280004969 | 1.88 | null | Palliative (P) | 2014-05-21 | 2015-06-07 | Cetuximab 7 day (Cycle 1) | N | Y | 280025271 | CETUXIMAB |
| 280007679 | 280004970 | 1.8 | 73.2 | Palliative (P) | 2017-09-02 | 2017-09-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025273 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007680 | 280008632 | 1.65 | 71.2 | Palliative (P) | null | 2013-12-29 | Carboplatin AUC 6 - 10 | 02 | N | 280025273 | CARBOPLATIN |
| 280007681 | 280008632 | 1.61 | null | null | 2015-05-13 | 2015-06-02 | Cetuximab 14 day | N | null | 280025273 | CETUXIMAB |
| 280007682 | 280004971 | 1.59 | 52.4 | Curative (C) | 2015-12-05 | 2016-05-04 | NB HRNBL-1 Isotretinoin | 02 | N | 280025277 | NOT MATCHED |
| 280007683 | 280004974 | 1.92 | 39.2 | Neo-adjuvant (N) | 2013-05-15 | 2014-12-11 | DOCETAXEL + GEMCITABINE | 02 | null | 280025279 | DOCETAXEL + GEMCITABINE |
| 280007684 | 280004975 | 1.99 | 68.5 | Curative (C) | 2017-10-16 | 2017-10-28 | Cetuximab 7 day (>Cycle 2) | N | N | 280025280 | CETUXIMAB |
| 280007685 | 280004976 | 1.65 | 65.6 | Curative (C) | 2016-10-19 | 2016-10-27 | Carboplatin AUC 2 - 5 | N | N | 280025283 | CARBOPLATIN |
| 280007686 | 280004977 | 1.91 | 81.8 | Palliative (P) | 2016-08-21 | 2016-08-21 | Cetuximab 7 day (>Cycle 2) | N | null | 280025284 | CETUXIMAB |
| 280007687 | 280004978 | 0 | 71.2 | Curative (C) | 2013-10-01 | 2013-10-11 | NB HRNBL-1 BUMEL MAT | N | N | 280025284 | NOT MATCHED |
| 280007688 | 280004978 | null | 70.9 | Palliative (P) | 2015-01-17 | 2015-02-28 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 280025284 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007689 | 280012002 | null | 98 | Neo-adjuvant (N) | 2014-10-18 | 2016-01-16 | WT SIOP 2002 01 post op VA | null | N | 280025289 | NOT MATCHED |
| 280007690 | 280004980 | null | 78 | Curative (C) | 2015-10-21 | 2015-11-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025293 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007691 | 280004982 | null | 67 | Curative (C) | 2013-05-05 | 2013-09-13 | EW EuroEwing 2012 Arm A VAC | N | Y | 280025295 | NOT MATCHED |
| 280007692 | 280004982 | 1.56 | null | Neo-adjuvant (N) | 2016-12-22 | 2017-01-01 | DOCETAXEL + GEMCITABINE | 02 | N | 280025295 | DOCETAXEL + GEMCITABINE |
| 280007693 | 280004983 | null | null | Curative (C) | 2015-07-29 | 2015-08-06 | Cisplatin + Docetaxel +Fluorouracil | Y | Y | 280025300 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007694 | 280004983 | 1.61 | 43.4 | null | 2017-09-16 | 2017-10-29 | Cetuximab 7 day (>Cycle 2) | N | N | 280025300 | CETUXIMAB |
| 280007695 | 280004983 | 1.71 | 91.9 | Curative (C) | 2014-10-22 | 2014-11-29 | Cetuximab 7 day (Cycle 1) | Y | Y | 280025300 | CETUXIMAB |